Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women-Reference-Cited by-同舟云学术

Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women

Published:2019-09-01 Issue:1 Volume:82 Page:41-45
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

LaCourse Sylvia M.,Wagner Anjuli D.,Cranmer Lisa M.,Copeland Audrey,Maleche-Obimbo Elizabeth,Richardson Barbra A.,Matemo Daniel,Kinuthia John,John-Stewart Grace

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference23 articles.

1. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps;Mathad;Clin Infect Dis.,2012

2. Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus;Gupta;J Infect Dis.,2011

3. Impact of tuberculosis exposure at home on mortality in children under 5 years of age in Guinea-Bissau;Gomes;Thorax,2011

4. Poor obstetric and infant outcomes in HIV-infected pregnant women with tuberculosis in South Africa: the tshepiso study;Salazar-Austin;Clin Infect Dis.,2018

5. Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program;Haas;Clin Infect Dis.,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya;The International Journal of Tuberculosis and Lung Disease;2023-12-01

2. Tuberculosis Infection in Pregnant People: Current Practices and Research Priorities;Pathogens;2022-12-06

3. Pregnancy in Women With HIV in a Tuberculosis Preventive Therapy Trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-12-01

4. Interferon Gamma Release Assay and Tuberculin Skin Test Performance in Pregnant Women Living With and Without HIV;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-01-01

5. Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women;Clinical Infectious Diseases;2021-07-29